The Synapse Critical Care & Emergency Medicine Podcast
The Synapse is a Critical Care and Emergency Medicine podcast breaking down topics and case studies into simple easy-to-digest segments to help build paramedic, nurse, and other pre-hospital and hospital clinicians into more robust providers. This podcast is open to any and all Emergency Medicine and Critical Care healthcare providers both in and out-of-hospital. Every effort is made to put out as many various topics to cater to everyone's interests and levels. Leave your technician hat outside, put on your clinician hat, and join us!
**Disclosures:
1) This is a non-monetary podcast, created and edited for free for your enjoyment and learning purposes.
2) The opinions and information presented in these podcast episodes is based off of up-to-date research, the latest evidence-based-guidelines, and/or anecdotal experience/opinions of the author.
3) Under no circumstances does this podcast or the information presented within each episode serve as authorization to work outside your guidelines, protocols, or workplace rules otherwise. When in doubt, contact Medical Control for guidance.
The Synapse Critical Care & Emergency Medicine Podcast
The Synapse Season 3 Episode 29 - Goodbye Andexxa...and FDA Rapid Approval?
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
This episode is both a notice to providers about Andexxa's removal from the market for DOAC reversal, specifically Eliquis and Xarelto, as well as a dive into the FDA's rapid approval process for drugs that propose to be game-changers for lifesaving conditions. The evidence just didn't pan out for this specific drug, and it leaves questions about how the FDA approves drugs on the quick track process, and how they review them after approval is granted. What happens next?
